Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04728399
What this trial is testing

Soy Peptide, Conjugated Linoleic Acid, Overweight or Obese, Body Composition

Who this might be right for
Overweight or Obesity
Fangfang Zeng 120
Not applicableStudy completedNCT06101433
What this trial is testing

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

Who this might be right for
NAFLD
Ahvaz Jundishapur University of Medical Sciences 46
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Early research (Phase 1)Study completedNCT06052566
What this trial is testing

Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

Who this might be right for
Non-alcoholic SteatohepatitisHepatic Impairment
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Study completedNCT01399645
What this trial is testing

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisType 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM) 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Testing effectiveness (Phase 2)Ended earlyNCT03676231
What this trial is testing

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Second Genome 9
Not applicableStudy completedNCT02196831
What this trial is testing

Tesamorelin Effects on Liver Fat and Histology in HIV

Who this might be right for
Human Immunodeficiency Virus (HIV)Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
Massachusetts General Hospital 61
Testing effectiveness (Phase 2)Study completedNCT01919294
What this trial is testing

Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)

Who this might be right for
Nonalcoholic SteatohepatitisHypogonadism
Sheffield Teaching Hospitals NHS Foundation Trust 3
Not applicableLooking for participantsNCT06720766
What this trial is testing

Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity

Who this might be right for
Fatty Liver Disease
The Third People's Hospital of Chengdu 600
Not applicableStudy completedNCT04180631
What this trial is testing

Quantitative US for Hepatic Steatosis

Who this might be right for
Hepatic Steatosis
Seoul National University Hospital 124
Testing effectiveness (Phase 2)Study completedNCT02927184
What this trial is testing

Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease

Who this might be right for
HyperlipidemiaNAFLD
Viking Therapeutics, Inc. 59
Not applicableUnknownNCT02810821
What this trial is testing

Gonadal Hormone, Gonadotropin and Cardiovascular Events

Who this might be right for
AgingMenopause
Shandong Provincial Hospital 8,000
Testing effectiveness (Phase 2)Ended earlyNCT02855164
What this trial is testing

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 350
Not applicableStudy completedNCT02650830
What this trial is testing

Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress

Who this might be right for
Type 2 DiabetesPrediabetesNon-alcoholic Fatty Liver Disease+1 more
Yonsei University 362
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Not applicableStudy completedNCT01828528
What this trial is testing

Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Sheba Medical Center 26
Not applicableStudy completedNCT04232293
What this trial is testing

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2NAFLDNASH
Nantes University Hospital 722
Not applicableStudy completedNCT02513121
What this trial is testing

Dietary Treatment Study of Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease
University of California, San Diego 40
Not applicableUnknownNCT02792634
What this trial is testing

Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery

Who this might be right for
Bariatric Surgery CandidateNonalcoholic SteatohepatitisObesity
RWTH Aachen University 200
Next Page